Zobrazeno 1 - 10
of 441
pro vyhledávání: '"Arrestin beta 2"'
Autor:
Chanjuan Xu, Jiayu Zheng, Yingxuan Wang, Yuhua Liao, Yanzhao Zhou, Zhihua Qiu, Xiaole Yan, Zhiran Fan, Qingchen Yuan, Xiao Chen
Publikováno v:
Biochemical and Biophysical Research Communications. 544:1-7
Background Our previous study developed ATRQβ-001 vaccine, which targets peptide ATR001 from angiotensin Ⅱ (Ang Ⅱ) receptor type 1 (AT1R). The ATRQβ-001 vaccine could induce the production of anti-ATR001 monoclonal antibody (McAb-ATR) and inhib
Autor:
Fernando A.C. Seara, Guorui Deng, Justin L. Grobe, Pablo Nakagawa, Curt D. Sigmund, Sadashiva S. Karnik, Natalia M Mathieu, Mario Zanaty, Kirthikaa Balapattabi
Publikováno v:
Hypertension. 77:420-431
Activation of central AT 1 Rs (angiotensin type 1 receptors) is required for the increased blood pressure, polydipsia, and salt intake in deoxycorticosterone acetate (DOCA)–salt hypertension. TRV120027 (TRV027) is an AT 1 R-biased agonist that sele
Publikováno v:
The Journal of Biological Chemistry
G protein–coupled receptors (GPCRs) initiate signaling cascades via G-proteins and beta-arrestins (βarr). βarr-dependent actions begin with recruitment of βarr to the phosphorylated receptor tail and are followed by engagement with the receptor
Autor:
Yao Lu, Daisy L Spark, Christopher J. Langmead, Gregory D. Stewart, Cassandra J Hatzipantelis
Publikováno v:
ACS Chemical Neuroscience. 11:2077-2084
The orphan Gαs-coupled receptor GPR52 is expressed exclusively in the brain, predominantly in circuitry relating to symptoms of neuropsychiatric and cognitive disorders such as schizophrenia. While GPR52 agonists have displayed antipsychotic and pro
Autor:
Karst, Henk, den Boon, Femke S, Vervoort, Niek, Adrian, Max, Kapitein, Lukas C, Joëls, Marian, Sub Cell Biology, Celbiologie
Publikováno v:
Molecular and Cellular Endocrinology, 541, 1. Elsevier Ireland Ltd.
Molecular and Cellular Endocrinology, 541:111501. ELSEVIER IRELAND LTD
Molecular and Cellular Endocrinology, 541:111501. ELSEVIER IRELAND LTD
Corticosteroid receptors in the mammalian brain mediate genomic as well as non-genomic actions. Although receptors mediating genomic actions were already cloned 35 years ago, it remains unclear whether the same molecules are responsible for the non-g
Autor:
Jordan T. Bateman, Erica S. Levitt
Publikováno v:
Am J Physiol Cell Physiol
Respiratory depression is a potentially fatal side effect of opioid analgesics and a major limitation to their use. G protein-biased opioid agonists have been proposed as “safer” analgesics with less respiratory depression. These agonists are bia
Publikováno v:
Neuropharmacology
G protein-coupled receptors (GPCR) have a long history of being considered a prime target for drug development to treat a plethora of diseases and disorders. In fact in 1827, the first approved therapeutic in the United States was morphine, a drug th
Publikováno v:
Molecular and Cellular Endocrinology. 487:24-33
The peptide hormone relaxin mediates many biological actions including anti-fibrotic, vasodilatory, angiogenic, anti-inflammatory, anti-apoptotic, and organ protective effects across a range of tissues. At the cellular level, relaxin binds to the G p
Autor:
Jeffrey J. Kovacs, Zhiyuan Ma, Cristian T. Badea, Claude A. Piantadosi, Xinyu Xiong, Sudarshan Rajagopal, Suzy Comhair, Yen-Rei A. Yu
Publikováno v:
Am J Respir Cell Mol Biol
Background: Receptor signaling is central to vascular endothelial function and is dysregulated in vascular diseases such as atherosclerosis and pulmonary arterial hypertension (PAH). Signaling pathways involved in endothelial function include vascula
Autor:
Yi Shi, Yu-Ling Yin, Ping Liu, Guanguan Zhao, Xiaoxi Wang, H. Eric Xu, Yi Jiang, Ting Wang, Li Hou, Man Wang
Publikováno v:
Acta Pharmacol Sin
5-HT(4)R, 5-HT(6)R, and 5-HT(7A)R are three constitutively active G(s)-coupled 5-HT receptors that have key roles in brain development, learning, memory, cognition, and other physiological processes in the central nervous system. In addition to G(s)